These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38081104)

  • 1. Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson's disease.
    Mohammed OA; Elballal MS; El-Husseiny AA; Khidr EG; El Tabaa MM; Elazazy O; Abd-Elmawla MA; Elesawy AE; Ibrahim HM; Abulsoud AI; El-Dakroury WA; Abdel Mageed SS; Elrebehy MA; Nomier Y; Abdel-Reheim MA; El-Husseiny HM; Mahmoud AMA; Saber S; Doghish AS
    Pathol Res Pract; 2024 Jan; 253():155023. PubMed ID: 38081104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA Dysregulation in Parkinson's Disease: A Narrative Review.
    Nies YH; Mohamad Najib NH; Lim WL; Kamaruzzaman MA; Yahaya MF; Teoh SL
    Front Neurosci; 2021; 15():660379. PubMed ID: 33994934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.
    Leggio L; Vivarelli S; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Marchetti B; Iraci N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases.
    Dorostgou Z; Yadegar N; Dorostgou Z; Khorvash F; Vakili O
    J Neurosci Res; 2022 Sep; 100(9):1775-1790. PubMed ID: 35642104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease: Autoimmunity and neuroinflammation.
    De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
    Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson's Disease.
    Guedes BFS; Cardoso SM; Esteves AR
    Biomedicines; 2023 May; 11(5):. PubMed ID: 37239020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy.
    Paccosi E; Proietti-De-Santis L
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease and microRNAs - Lessons from model organisms and human studies.
    Evans B; Furlong HA; de Lencastre A
    Exp Gerontol; 2021 Nov; 155():111585. PubMed ID: 34634413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in the epigenetic regulation of disease progression in Parkinson's disease.
    Selvakumar SC; Preethi KA; Tusubira D; Sekar D
    Front Cell Neurosci; 2022; 16():995997. PubMed ID: 36187290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy in Parkinson's disease: rationale and current status.
    Feng LR; Maguire-Zeiss KA
    CNS Drugs; 2010 Mar; 24(3):177-92. PubMed ID: 20155994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.
    Sarkar S; Raymick J; Imam S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of Parkinson's disease: present and future.
    Miller DB; O'Callaghan JP
    Metabolism; 2015 Mar; 64(3 Suppl 1):S40-6. PubMed ID: 25510818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Analysis of miRNAs in PD Stress Condition: miR-5701 Modulates Mitochondrial-Lysosomal Cross Talk to Regulate Neuronal Death.
    Prajapati P; Sripada L; Singh K; Roy M; Bhatelia K; Dalwadi P; Singh R
    Mol Neurobiol; 2018 Jun; 55(6):4689-4701. PubMed ID: 28710704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review).
    Ma Z; Liang H; Hu B; Cai S; Yan D
    Int J Mol Med; 2023 Jun; 51(6):. PubMed ID: 37144489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances with microRNAs in Parkinson's disease research.
    Ma L; Wei L; Wu F; Hu Z; Liu Z; Yuan W
    Drug Des Devel Ther; 2013; 7():1103-13. PubMed ID: 24109179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifactorial sleep disturbance in Parkinson's disease.
    Albers JA; Chand P; Anch AM
    Sleep Med; 2017 Jul; 35():41-48. PubMed ID: 28619181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALAT1 lncRNA and Parkinson's Disease: The role in the Pathophysiology and Significance for Diagnostic and Therapeutic Approaches.
    Abrishamdar M; Jalali MS; Rashno M
    Mol Neurobiol; 2022 Sep; 59(9):5253-5262. PubMed ID: 35665903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease.
    Béné R; Antić S; Budisić M; Lisak M; Trkanjec Z; Demarin V; Podobnik-Sarkanji S
    Acta Clin Croat; 2009 Sep; 48(3):377-80. PubMed ID: 20055267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.
    Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.